Vascular endothelial growth factor inhibitors: investigational therapies for the treatment of psoriasis
Anja K Weidemann,1 Ania A Crawshaw,2 Emily Byrne,3 Helen S Young1 1The Dermatology Centre, Salford Royal NHS Foundation Trust, The University of Manchester, Manchester, UK; 2Royal Sussex County Hospital, Brighton, UK; 3University Hospital of South Manchester, Manchester, UK Abstract: Psoriasis is a...
Saved in:
Main Authors: | Weidemann AK (Author), Crawshaw AA (Author), Byrne E (Author), Young HS (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2013-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014) -
Nephrotoxicity induced by vascular endothelial growth factor inhibitors
by: Shirinsadat Badri, et al.
Published: (2022) -
Aortic dissection induced by vascular endothelial growth factor inhibitors
by: Shuqi Dai, et al.
Published: (2023) -
Inhibition of vascular endothelial growth factor‐A downregulates angiogenesis in psoriasis: A pilot study
by: Andrea Luengas‐Martinez, et al.
Published: (2023) -
Assessing the association between psoriasis and cardiovascular ischemia: An investigation of vascular endothelial growth factor, cutaneous angiogenesis, and arterial stiffness
by: Alpana Mohta, et al.
Published: (2023)